600488 津药药业
2024/06 - 中期2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)4.7673.9501.1871.6261.132
总资产报酬率 ROA (%)2.3191.8300.5450.7770.572
投入资产回报率 ROIC (%)3.4922.6530.7621.0750.791

边际利润分析
销售毛利率 (%)46.20346.42549.07347.63446.006
营业利润率 (%)10.6984.4781.9033.8904.249
息税前利润/营业总收入 (%)10.9684.9021.1325.1835.029
净利润/营业总收入 (%)9.8504.3000.5002.8992.585

收益指标分析
经营活动净收益/利润总额(%)119.662114.5091,621.443122.055146.858
价值变动净收益/利润总额(%)0.536-0.669-179.2553.344-1.087
营业外收支净额/利润总额(%)0.854-0.694-460.9192.169-17.833

偿债能力分析
流动比率 (X)1.2631.0861.0350.9301.045
速动比率 (X)0.8000.7130.5280.4480.433
资产负债率 (%)37.10038.89643.55739.84538.916
带息债务/全部投入资本 (%)21.09223.92133.61731.61228.785
股东权益/带息债务 (%)353.895300.551187.495206.843232.210
股东权益/负债合计 (%)132.680123.622102.611118.388124.467
利息保障倍数 (X)61.67510.7751.4284.2953.533

营运能力分析
应收账款周转天数 (天)43.54836.73941.14442.24137.665
存货周转天数 (天)141.303167.252204.385190.760259.293